Brief: Amylyx Pharmaceuticals Q1 EPS USD -1.75
09/05/2024 12:00
May 09 (Reuters) - Amylyx Pharmaceuticals Q1 net income USD -118.793 million. * Q1 operating income USD -122.13 million * Q1 pretax profit USD -118.551 million * Q1 operating expenses USD 210.773 million * Q1 cash & investments USD 373.3 million
Recent news on Amylyx Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-LSI Industries, SiTime, Andersen Group
U.S. STOCKS ON THE MOVE-Apple, Hims & Hers Health, Sysco
U.S. STOCKS ON THE MOVE-Nordson, Nebius, Deere
Amylyx dips after increased $500 mln stock sale to fund blood sugar drug
Brief: Amylyx Pharmaceuticals Announces Pricing Of Upsized $500 Million Underwritten Public Offering Of Common Stock